GlaxoSmithKline PLC (LSE:GSK) - Overview

Stock Report

GlaxoSmithKline PLC GSK

Last Price
GBX1,467.00

Day Change
4.50|0.31%

As of 08/12/2016
09:31:38 GMT | GBX
Minimum 15 Minutes Delay.

Last Close1,462.50p
Day Range1,461.00 - 1,470.00
Mkt Cap71.31Bil
52-Wk Range1,277.25 - 1,745.56
Yield %5.45
ISINGB0009252882
Volume1,553,971
P/E96.12
P/S2.96
P/CF37.09

Share Price

Total Returns 07/12/2016

 Chg (%)  
More ...
GlaxoSmithKline PLC-5.58 
FTSE 100 TR GBP1.82
 
Financials
201320142015
More ...
Income Statement
Turnover26,505.0023,006.0023,923.00
Operating Profit7,028.003,597.0010,322.00
Net Profit5,628.002,831.008,372.00
Reported EPS110.5056.70172.30
Balance Sheet
Current Assets15,226.0013,522.0016,541.00
Non Current Assets26,859.0025,973.0036,859.00
Total Assets42,086.0040,651.0053,446.00
Current Liabilities13,677.0013,295.0013,417.00
Total Liabilities34,274.0035,715.0044,568.00
Total Equity7,812.004,936.008,878.00
Cash Flow
Operating Cash Flow8,499.006,284.004,631.00
Net Change in Cash1,473.00-1,287.001,503.00
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20165,804.6399.50551.9214.700.0380.005.47
20176,180.20102.352.8614.294.9980.005.47

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
01/12/2016Exercise of OptionMr. Simon Dingemans1,247.002162,694.00
09/11/2016PurchaseSir Andrew Witty1,592.678127.00
09/11/2016Transfer inSir Andrew Witty0.0080.00
09/11/2016PurchaseMr. Simon Dingemans1,592.678127.00

Company Profile

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products.
 

Sector

Drug Manufacturers - Major

Market Position

5 of 1865 Companies

Index

FTSE 100 ,FTSE 350 ,FTSE Eurotop 100 ,S&P Europe 350 ,Eurotop 300

Outlook

(27/07/2016) no outlook statement

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)14.3213.1215.86
Div Yld (E)5.474.254.26
PEG (E)1.640.200.15
ROCE40.34209.39-30.49
Op Mrgn22.66-16.09-33.54
EPS Grwth8.7110.0923.13
Dividends
PreviousLatest
More ...
Record Date12/08/1604/11/16
Ex-Div11/08/1603/11/16
Paid13/10/1612/01/17
Amnt19.0019.00

Broker Sentiment

Strong Buy0
Buy2
Hold2
Sell1
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanSir Philip Hampton
Chief Executive OfficerSir Andrew Witty
Chief Financial OfficerMr. Simon Dingemans
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.